Nutrien's Earnings and Revenues Surpass Estimates in Q3, Up Y/Y

Core Insights - Nutrien Ltd. reported a significant profit increase to $496 million or 96 cents per share for Q3 2025, up from $25 million or 4 cents in the same quarter last year, with adjusted earnings per share at 97 cents, surpassing the Zacks Consensus Estimate of 93 cents [1][8] - Sales rose approximately 12% year over year to $6,007 million, exceeding the Zacks Consensus Estimate of $5,827 million [1][8] Segment Performance - The Nutrien Ag Solutions (Retail) segment saw a 5% year-over-year sales increase to $3,427 million, although it fell short of the estimate of $4,338 million [2] - The Potash division experienced a 27% year-over-year sales rise, totaling $1,122 million, beating the estimate of $456 million, driven by strong demand in North America and offshore [3] - The Nitrogen segment reported sales of $1,063 million, up approximately 34% year over year, exceeding the estimate of $809 million, supported by strong demand and higher production [3] - The Phosphate segment generated sales of $495 million, reflecting a 20% year-over-year increase, surpassing the estimate of $255 million [4] Financial Overview - At the end of the quarter, Nutrien had cash and cash equivalents of $624 million, a 20% year-over-year increase, while long-term debt remained flat at $10,390 million [5] - Cash used in operating activities was reported at $426 million for the quarter [5] Future Outlook - The company projects retail adjusted EBITDA for 2025 to be between $1.68 billion and $1.82 billion, anticipating stronger crop nutrient and crop protection sales in the latter half of the year [6] - Potash sales volume guidance has been raised to 14–14.5 million tons, driven by expected higher global demand [6] - Nitrogen sales volumes are forecasted at 10.7–11 million tons, excluding additional sales from Trinidad operations for the remainder of 2025 [6] - Phosphate sales volumes are expected to be between 2.35 and 2.55 million tons, supported by improved operating rates [7] - Capital expenditures are projected at $2–$2.1 billion, which is below last year's level, including $400–$500 million for growth investments [7]